Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dormann

Showing results (311-320 of 418) with videos related to

Pageof 42
Sort By:
European Journal of Clinical Pharmacology|March 22, 2014
Application of the Pareto principle to identify and address drug-therapy safety issuesFabian Müller, Harald Dormann, Barbara Pfistermeister, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Drug Safety|February 15, 2000
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reportingH Dormann, U Muth-Selbach, S Krebs, et al.
Journal of Neurochemistry|June 16, 2009
Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulinDorothee Dormann, Anja Capell, Aaron M Carlson, et al.
Nature|October 14, 2005
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylationWolfgang Fischle, Boo Shan Tseng, Holger L Dormann, et al.
Nature Chemical Biology|April 17, 2025
Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networksKristina Wagner, Jan Keiten-Schmitz, Bikash Adhikari, et al.
Frontiers in Pharmacology|May 24, 2021
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED StudyKatja S Just, Harald Dormann, Mathias Freitag, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 20, 2026
[Geriatric care assistance in emergency departments: position paper of DGIIN, DGINA, and DGG]Guido Michels, Susanne Schuster, Patrick Dormann, et al.
Developmental Cell|August 18, 2012
The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopmentMattia Frontini, Alexander Kukalev, Elisabetta Leo, et al.
Pageof 42

Showing results (311-320 of 418) with videos related to

Sort By:
Pageof 42
European Journal of Clinical Pharmacology|March 22, 2014
Application of the Pareto principle to identify and address drug-therapy safety issuesFabian Müller, Harald Dormann, Barbara Pfistermeister, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Drug Safety|February 15, 2000
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reportingH Dormann, U Muth-Selbach, S Krebs, et al.
Journal of Neurochemistry|June 16, 2009
Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulinDorothee Dormann, Anja Capell, Aaron M Carlson, et al.
Nature|October 14, 2005
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylationWolfgang Fischle, Boo Shan Tseng, Holger L Dormann, et al.
Nature Chemical Biology|April 17, 2025
Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networksKristina Wagner, Jan Keiten-Schmitz, Bikash Adhikari, et al.
Frontiers in Pharmacology|May 24, 2021
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED StudyKatja S Just, Harald Dormann, Mathias Freitag, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 20, 2026
[Geriatric care assistance in emergency departments: position paper of DGIIN, DGINA, and DGG]Guido Michels, Susanne Schuster, Patrick Dormann, et al.
Developmental Cell|August 18, 2012
The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopmentMattia Frontini, Alexander Kukalev, Elisabetta Leo, et al.
Pageof 42